Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Nexentis Technologies Inc. (NXTS : NSDQ)

• Company Description    Nexentis Technologies Inc. is a drug discovery company which also invests in solar energy assets based on the RTB business model. The company's drug discovery engaged in targeting cancer and inflammatory metabolic disease indications through the mitochondrial SLC25 protein family. Nexentis Technologies Inc. is based in Neve Yarak, Israel. Number of Employees: 9

• Price / Volume Information    Yesterday's Closing Price: $1.72 Daily Weekly Monthly 20 Day Moving Average: 30,861 shares Shares Outstanding: 1.45 (millions) Market Capitalization: $2.50 (millions) Beta: 1.85 52 Week High: $58.75 52 Week Low: $1.43 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -10.65% -10.75% 12 Week -65.67% -67.11% Year To Date -85.37% -87.37%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL Pinhas Sapir St. 3 Kiryat HaMada - Ness Ziona,L3 7403626 ISR ph: 347-468-9583 fax: - alon.silberman@mitocarexbio.com http://www.nexentistech.com

• General Corporate Information    Officers David Palach - Chief Executive Officer Amitay Weiss - Chairman of the Board of Director Lital Barda - Chief Financial Officer Ronen Rosenbloom - Director Eliahou Arbib - Director Peer Information Nexentis Technologies Inc. (DLP) Nexentis Technologies Inc. (CPKPY) Nexentis Technologies Inc. (ABTXQ) Nexentis Technologies Inc. (ADM) Nexentis Technologies Inc. (CRESY) Nexentis Technologies Inc. (PYYX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: AGRI OPERATIONS Sector: Consumer Staples CUSIP: 80512Q600 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/26 Next Expected EPS Date: 11/12/26 Share - Related Items Shares Outstanding: 1.45 Most Recent Split Date: 4.00 (0.14:1) Beta: 1.85 Market Capitalization: $2.50 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/12/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 1.40 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: 41.06% vs. Previous Quarter: -114.55% Sales Growth vs. Year Ago Period: 655.56% vs. Previous Quarter: -% ROE 06/30/26 - -304.79 03/31/26 - -146.70 12/31/25 - -112.68 ROA 06/30/26 - -178.91 03/31/26 - -113.01 12/31/25 - -81.47 Current Ratio 06/30/26 - 3.72 03/31/26 - 4.73 12/31/25 - 4.19 Quick Ratio 06/30/26 - 3.72 03/31/26 - 4.73 12/31/25 - 4.19 Operating Margin 06/30/26 - - 03/31/26 - - 12/31/25 - - Net Margin 06/30/26 - - 03/31/26 - - 12/31/25 - - Pre-Tax Margin 06/30/26 - -25,363.63 03/31/26 - -15,066.67 12/31/25 - - Book Value 06/30/26 - 1.23 03/31/26 - 17.61 12/31/25 - 39.70 Inventory Turnover 06/30/26 - 0.00 03/31/26 - 0.00 12/31/25 - 0.00 Debt-to-Equity 06/30/26 - 0.12 03/31/26 - 0.01 12/31/25 - 0.02 Debt-to-Capital 06/30/26 - 10.41 03/31/26 - 0.79 12/31/25 - 1.48

Powered by Zacks Investment Research ©